BeStock  
Stocks › Biotechnology › DFTX

Definium Therapeutics DFTX

US equityMarket cap rank #2233Biotechnology
$28.34 −$1.14 (-3.87%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.05 -1.02%
Open$29.14
Prev close$29.48
Day range$28.18 – $29.51
Volume3.24M
Market cap$3.88B
P/E (TTM)–
Dividend yield–

DFTX Stock News

Headlines matching Definium Therapeutics or the DFTX ticker, most recent first.

  • LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $75Market news · 9 Sep 2026 · Direct mention
  • CCORF Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $64Market news · 2 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $78Market news · 19 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)TipRanks · 19 Sep 2026 · Direct mention
  • Stifel Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Raises Target Price to $67 PositiveMarket news · 16 Sep 2026 · Direct mention
  • Maxim Group Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $55Market news · 16 Sep 2026 · Direct mention
  • JonesTrading Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $90Market news · 15 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $66 to $91Market news · 15 Sep 2026 · Direct mention
  • RBC Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $66Market news · 11 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $50 to $75Market news · 8 Aug 2026 · Direct mention
  • Stifel Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $60Market news · 31 Aug 2026 · Direct mention
  • Wells Fargo Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $72Market news · 31 Aug 2026 · Direct mention
  • BofA Securities Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $75Market news · 18 Aug 2026 · Direct mention
  • BofA Securities Initiates Definium Therapeutics(DFTX.US) With Buy Rating, Announces Target Price $75Market news · 18 Aug 2026 · Direct mention
  • Piper Sandler Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $75Market news · 17 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on DFTX.

Sign in to join the discussion.

Scroll to Top